Department of Health and Social Care written question – answered at on 24 April 2018.
To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to ensure that the Medicines and Healthcare products Regulatory Agency will be supported to maintain its status as a world-leading regulator.
The Medicines and Healthcare products Regulatory Agency (MHRA) is a strong national regulator with substantial capacity and expertise to regulate and evaluate the safety of our medicines and medical devices. The Agency is recognised globally for its expertise in licensing, inspections and batch release, and their pharmacovigilance regime is globally recognised and respected. Furthermore, the Agency is considered a leader within the European Union regulatory framework.
The Government has been clear about our desire to negotiate a close relationship with the EU, including exploring with the EU the terms on which the United Kingdom could remain part of the European Medicines Agency. This was reinforced by my Rt. hon. Friend the Prime Minister in her Mansion House speech of 2 March. Nevertheless the MHRA will seek to become an even more influential partner internationally in its own right, and is committed to being a global leader, focusing on raising the quality of standards across the world.
The Agency is also committed to continuing cooperation with international fora, including the International Medical Device Regulators Forum, the International Coalition of Medicines Regulatory Authorities and the International Council for Harmonisation of Technical Requirements for Human Use. The form that UK participation takes in some of these groups will depend on the outcome of the Future Economic Partnership negotiations with the EU.
Yes0 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.